Brief: Medipost Acquires Patent For The Treatment Of Neural Diseases In U.S.
16/01/2019 01:21
Jan 16 (Reuters) - Medipost Co Ltd 078160.KQ :
* SAYS ACQUIRES PATENT ON COMPOSITION FOR THE TREATMENT OF
NEURAL
DISEASES IN U.S.
Source text for Eikon: https://bit.ly/2ALymQA
Further company coverage: 078160.KQ
((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))
Recent news on Medipost Co
See all newsBrief: Medipost's Cartistem® Meets All Primary And Secondary Endpoints In Japan Phase 3 Trial And Demonstrates Statistically Significant Efficacy Gains Versus Active Control
Brief: Medipost Inc. Submits Ind Amendment With U.S. Food And Drug Administration To Initiate Phase Iii Trial
Brief: Medipost Co Q3 Operating Profit 2 Billion Won, Swings To Profit From Year Earlier
Brief: Medipost To Conduct Capital Increase Of 120 Billion Won
Brief: Medipost Co To Acquire 46 Billion Won Worth Of Shares In Unit Medipost America